Advisory Committee to the Director
Centers for Disease Control and Prevention

Alan Greenberg, MD, MPH

Alan Greenberg, MD, MPH, is a Professor and Chair of the Department of Epidemiology and Biostatistics at George Washington University School of Public Health and Health Services. He is also Professor in the Departments of Medicine and of Microbiology, Immunology, and Tropical Medicine in the School of Medicine and Health Sciences.

Among recent activities, Dr. Greenberg is the Co-founder and Co-Director of the GW HIV/AIDS Institute, dedicated to linking and expanding the University′s HIV-related research and educational activities in basic science, prevention, epidemiology, clinical care, education and health policy. He also founded and is Director of the newly chartered GW Center for HIV/AIDS Epidemiology, Biostatistics and Public Health Laboratory Research, committed to expanding HIV/AIDS research activities in these domains in Washington, DC. He is the principal investigator of the “Academic-Public Health Partnership” between GW and the District of Columbia Department of Health. The partnership has focused on core HIV/AIDS and hepatitis surveillance activities, the CDC-funded National HIV Behavioral Surveillance System, and monitoring and evaluation of DC′s HIV testing campaign. He is also the principal investigator of several World Health Organization-sponsored management and policy projects, including the development of a legal and policy framework to support “task-shifting” among health care workers to scale up HIV prevention, care and treatment services in the developing world. Before joining SPHHS, Dr. Greenberg spent two decades at CDC, where he provided scientific leadership for its domestic and international HIV epidemiologic research program. He served as chief of the agency′s HIV Epidemiology Branch, supervising research studies in 28 US states and nine countries. His assignments have taken him around the globe, including Cote d′Ivoire, where he spent four years directing the CDC's research, training and clinical services in West Africa. He received his Doctor of Medicine from George Washington University School of Medicine in 1982 and his Masters in Public Health in 1999 from Harvard School of Public Health.

Kelly J. Henning, MD

Kelly J. Henning, MD, currently directs international health programs at the Bloomberg Foundation, New York City, including the $375 million Bloomberg Initiative to Reduce Tobacco Use, a global project aimed at curbing the tobacco epidemic in low and middle income countries. She received her medical training at the Tufts University School of Medicine and completed her internal medicine internship and residency at the University of Pennsylvania. Dr. Henning completed her infectious disease fellowship training at Memorial Sloan-Kettering Cancer Center in New York City. She received her epidemiology training in the Epidemic Intelligence Service at the US Centers for Disease Control and Prevention and assigned to the NYC Department of Health, Bureau of Communicable Diseases from 1990 to 1994. Subsequently, Dr. Henning worked in communicable disease surveillance, hospital epidemiology, and bioterrorism preparedness, serving as Assistant Professor at the Thomas Jefferson University School of Medicine and Associate Professor at the University of Pennsylvania, School of Medicine. From 2002 to 2003, she was a hospital epidemiologist at the Veteran′s Administration Hospital in Philadelphia, PA. With more than 20 years of experience in epidemiology and public health, Dr. Henning was the Director of the newly formed Division of Epidemiology at the New York City Department of Health and Mental Hygiene from 2003–2006 before joining the Bloomberg Foundation in January 2007.

George J. Isham, M.D., M.S.

Dr. George Isham is responsible for quality, utilization management, health promotion and disease prevention, research, and health professionals' education at HealthPartners. He is active in strategic planning and policy issues. He is a founding board member of the Institute for Clinical Systems Improvement, a collaborative of Twin Cities medical groups and health plans that is implementing clinical practice guidelines in Minnesota. Dr. Isham is a past member of the board of directors of the American's Health Insurance Plans and he is currently on the board of directors of the Alliance of Community Health Plans. He is past co-chair and current member of the National Committee for Quality Assurance's (NCQA) Committee on Performance Measurement which oversees health plan quality measurement standards.

He has served on the Center for Disease Control's (CDC) Task Force on Community Preventive Services and on the Agency for Healthcare Research and Quality's (AHRQ) Advisory Board for the National Guideline Clearinghouse. He has served on the Institute of Medicine's Board on Population Health and Public Health Services and chaired the committee that authored the report Priority Areas for National Action, Transforming Health Care Quality. In 2003, Dr. Isham was appointed as a lifetime National Associate of the National Academies of Science in recognition of his contributions to the work of the Institute of Medicine. Epidemic of Care, published in April 2003, with co-author George Halvorson, is Dr. Isham's examination of the impending healthcare crisis with suggestions on ways to solve it. Prior to his current position, Dr. Isham was medical director for MedCenters Health Plan in Minneapolis and executive director for University Health Care, Inc., in Madison, Wisconsin. His practice experience as a primary care physician includes eight years at the Freeport Clinic in Freeport, Illinois, and three and one-half years as clinical assistant professor in Medicine at the University of Wisconsin.

Anthony B. Iton, MD, JD, MPH

Anthony B. Iton, MD, JD, MPH, as Senior Vice President of Healthy Communities, joined The Endowment in October 2009.  Prior to his appointment at The Endowment, Dr. Iton served since 2003 as both the director and County Health Officer for the Alameda County Public Health Department.  In that role, he oversaw the creation of an innovative public health practice designed to eliminate health disparities by tackling the root causes of poor health that limit quality of life and lifespan in many of California's low-income communities.

Dr. Iton also served for three years as director of Health and Human Services and School Medical Advisor for the City of Stamford, Connecticut.  Concurrent to that, he also served as a physician in internal medicine for Stamford Hospital's HIV Clinic.  In addition, Dr. Iton served for five years as a primary care physician for the San Francisco Department of Public Health.
 His varied career also includes past service as a staff attorney and Health Policy analyst for the West Coast regional office of Consumer's Union, the publisher of Consumer Reports magazine.

Dr. Iton, who has been published in numerous public health and medical publications, is a regular public health lecturer and keynote speaker at conferences across the nation. He earned his BS in Neurophysiology, with honors, from McGill University, in Montreal, Quebec, his JD at the University of California, Berkeley's Boalt Hall School of Law, and his medical degree from Johns Hopkins University School of Medicine.

Mary Kelly

Ms. Kelly assumed the role of Executive Vice President, Merchandising and Category Management, with Shoppers Drug Mart in February 2009. She held various positions with Target Stores, Inc., since 1991 and most recently served as Vice President, General Merchandise Manager for Healthcare. In this role, she was responsible for managing all aspects of Target′s healthcare businesses including over the counter, prescription pharmacy, health clinics, and optical. In addition, she chaired Target's corporate health and wellness strategy committee and Target’s marketing committee. She also had responsibility for developing healthcare technology solutions. Mrs. Kelly is a registered pharmacist; and, before joining Target, she held positions at Revco Drug Stores and Eli Lilly and Company.

Jonathan T. Lord, MD

Jonathan Lord, MD, is Chairman of DexCom’s Board of Directors and has served as a director since 2008. Dr. Lord served as President and Chief Executive Officer of Navigenics, Inc. during 2009 and 2010 and serves on Navigenics′ board of directors. He also serves as a director of Stericyle Inc. and Veracyte Inc. Dr. Lord previously served as Chief Innovation Officer for Humana Inc. In that role, he was responsible for designing innovative health plan products and leading processes that enable people to navigate the healthcare system and support their health needs. Dr. Lord is a nationally recognized leader in the fields of e-health, health services, and quality improvement and physician leadership development and adjunct professor of Family and Community Medicine at Dartmouth Medical School in Hanover, New Hampshire. He is board-certified in anatomic and clinical pathology and in forensic pathology. He has authored and co-authored leading textbooks and book chapters on quality management, risk management, and ambulatory care.

Kenneth D. Mandl, MD, MPH

A pioneer in both consumer informatics and population health monitoring, Dr. Mandl has innovated and published extensively in the areas of personally controlled health records, disease outbreak detection, public health surveillance, and national health information infrastructure. Recognized for his teaching and research, he has received the Barger Award for Excellence in Mentoring at Harvard Medical School and the Presidential Early Career Award for Scientists and Engineers, the highest honor bestowed by the United States government to outstanding scientists and engineers.

Dr. Mandl co-directs a CDC Center of Excellence in Public Health Informatics. He is also a faculty member of the Harvard Medical School Center for Biomedical Informatics and affiliated faculty at the Harvard-MIT Division of Health Sciences and Technology.

Sara Rosenbaum, JD

Sara Rosenbaum, JD, is the Chair of the Department of Health Policy and Harold and Jane Hirsh Professor of Health Law and Policy, George Washington University. She also holds an appointment as Professor of Health Care Sciences at GW′s School of Medicine and Law. In addition to her responsibilities as chair, which she founded and developed, Professor Rosenbaum is Director of the Center for Health Policy Research, the institutional home for many of the department′s research activities, and Director of the Hirsh Health Law and Policy Program. Professor Rosenbaum has been named one of the nation′s 500 most influential health policy makers by McGraw Hill. Among other honors, she has received the Investigator Award in Health Policy from the Robert Wood Johnson Foundation and has been recognized by the Department of Health and Human Services for distinguished national service on behalf of Medicaid beneficiaries. As a member of the White House Domestic Policy Council under President Clinton, she directed the drafting of the Health Security Act and oversaw the development of the Vaccines for Children program.

Eduardo J. Sanchez, MD, MPH

Dr. Sanchez is Vice President and Chief Medical Officer for Blue Cross and Blue Shield of Texas. He was previously Director, Institute for Health Policy, at The University of Texas School of Public Health and is a Fellow of the American Academy of Family Physicians. He is the former Commissioner and State Health Officer of the Texas Department of State Health Services and was responsible for overseeing programs such as disease prevention, bioterrorism and disaster preparedness, family and community health services, and environmental and consumer safety and regulatory programs. Dr. Sanchez has extensive experience and knowledge of objectives and strategies for disease prevention and control, preparedness, and other public health issues.

John Reese Seffrin, PhD

Dr. Seffrin has been Chief Executive Officer at the American Cancer Society since 1992. During his leadership, the Society has become the world′s largest voluntary health organization fighting cancer with a billion dollars in resources to fund cancer research, advocacy, education, and service. Dr. Seffrin also serves as Adjunct Professor of Behavioral Science and Health Education at the Emory University Rollins School of Public Health and has served on numerous executive leadership committees and boards at the state and national levels. He has more than 100 published articles in journals, books, chapters in books, and other publications and has consulted, attended invited lectures, and presented in the areas of public health, global health, cancer prevention and control, smoking and health, diet, nutrition, screening, and health education.

M. Cass Wheeler

Cass Wheeler recently launched his consulting practice after a distinguished career with the American Heart Association, serving as its CEO from 1997 until 2008. He began his career with the association at its Texas affiliate in Austin in 1973, where he became vice president for field operations and later executive vice president. In 1992, Mr. Wheeler came to the national center in Dallas as Chief Operating Officer, assumed the position of Senior Vice President for field operations in 1996, and was named CEO in 1997. During his leadership, the American Heart Association merged its 56 state and metropolitan affiliates into 8 regional affiliates and adopted a single corporate structure. Mr. Wheeler is currently on the boards of American Legacy Foundation, the Paul G. Rogers Society for Global Health Research, and the Advisory Committee of the UCSF Center for Tobacco Control Research., and he previously served on the boards of the Partnership for Prevention, the National Center for Tobacco-Free Kids, the National Human Services Assembly, Research!America, Independent Sector, and the National Health Council.